Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment

In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical research 2023-10, Vol.40 (10), p.2291-2301
Hauptverfasser: Rahman, Sadia, Haque, Tasmima N., Sugandhi, Vrashabh V., Saraswat, Aishwarya L., Xin, Xiaoban, Cho, Hyunah
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2301
container_issue 10
container_start_page 2291
container_title Pharmaceutical research
container_volume 40
creator Rahman, Sadia
Haque, Tasmima N.
Sugandhi, Vrashabh V.
Saraswat, Aishwarya L.
Xin, Xiaoban
Cho, Hyunah
description In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells in vitro . Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice in vivo .
doi_str_mv 10.1007/s11095-023-03506-z
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2795358387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A773646598</galeid><sourcerecordid>A773646598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EotvCH-CAInHh4mJ77Ng-li0UpAUui8TNcpJxlCqJFzs5tL8ely1UIIR8GNnzvadnPUJecHbOGdNvMufMKsoEUAaK1fT2EdlwpYFaJr89JhumhaRGS35CTnO-ZowZbuVTcgKacaEANuTtPh6G1o_VNqGfqq1P6WaY--oyrT3dRd9hV332c-xxzFWIqfqEY7lOvtoXwTLhvDwjT4IfMz6_n2fk6_t3--0Huvty9XF7saOtlGKhtTe1DNAYNB5VzTkPoNoWWutlaBBsoxsrGQQumOnqoCTUhQMjFessKjgjr4--hxS_r5gXNw25xbHkwbhmJ7RVoAwYXdBXf6HXcU1zSeeEsdwCE5Y_UL0f0Q1ziEvy7Z2pu9Aaalkrawp1_g-qnA6noY0zhqG8_yEQR0GbYs4JgzukYfLpxnHm7opzx-JcKc79LM7dFtHL-8RrM2H3W_KrqQLAEchlNfeYHr70H9sfXi2gSQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2891930291</pqid></control><display><type>article</type><title>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Rahman, Sadia ; Haque, Tasmima N. ; Sugandhi, Vrashabh V. ; Saraswat, Aishwarya L. ; Xin, Xiaoban ; Cho, Hyunah</creator><creatorcontrib>Rahman, Sadia ; Haque, Tasmima N. ; Sugandhi, Vrashabh V. ; Saraswat, Aishwarya L. ; Xin, Xiaoban ; Cho, Hyunah</creatorcontrib><description>In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells in vitro . Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice in vivo .</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-023-03506-z</identifier><identifier>PMID: 37012533</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Biochemistry ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Cell Line, Tumor ; Controlled release ; Dermatologic agents ; Dermatology ; Drug Carriers ; Drug therapy ; Formulae, receipts, prescriptions ; Humans ; Medical Law ; Melanoma ; Melanoma - drug therapy ; Mice ; Micelles ; Nanogels ; Original Research Article ; Paclitaxel ; Particle size ; Pharmacology/Toxicology ; Pharmacy ; Polyethylene glycol ; Polyethylene Glycols ; Polylactide-co-glycolide ; Skin ; Temozolomide</subject><ispartof>Pharmaceutical research, 2023-10, Vol.40 (10), p.2291-2301</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>COPYRIGHT 2023 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</citedby><cites>FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</cites><orcidid>0000-0001-7150-4191</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11095-023-03506-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11095-023-03506-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37012533$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahman, Sadia</creatorcontrib><creatorcontrib>Haque, Tasmima N.</creatorcontrib><creatorcontrib>Sugandhi, Vrashabh V.</creatorcontrib><creatorcontrib>Saraswat, Aishwarya L.</creatorcontrib><creatorcontrib>Xin, Xiaoban</creatorcontrib><creatorcontrib>Cho, Hyunah</creatorcontrib><title>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells in vitro . Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice in vivo .</description><subject>Animals</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Cell Line, Tumor</subject><subject>Controlled release</subject><subject>Dermatologic agents</subject><subject>Dermatology</subject><subject>Drug Carriers</subject><subject>Drug therapy</subject><subject>Formulae, receipts, prescriptions</subject><subject>Humans</subject><subject>Medical Law</subject><subject>Melanoma</subject><subject>Melanoma - drug therapy</subject><subject>Mice</subject><subject>Micelles</subject><subject>Nanogels</subject><subject>Original Research Article</subject><subject>Paclitaxel</subject><subject>Particle size</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Polyethylene glycol</subject><subject>Polyethylene Glycols</subject><subject>Polylactide-co-glycolide</subject><subject>Skin</subject><subject>Temozolomide</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUFv1DAQhS0EotvCH-CAInHh4mJ77Ng-li0UpAUui8TNcpJxlCqJFzs5tL8ely1UIIR8GNnzvadnPUJecHbOGdNvMufMKsoEUAaK1fT2EdlwpYFaJr89JhumhaRGS35CTnO-ZowZbuVTcgKacaEANuTtPh6G1o_VNqGfqq1P6WaY--oyrT3dRd9hV332c-xxzFWIqfqEY7lOvtoXwTLhvDwjT4IfMz6_n2fk6_t3--0Huvty9XF7saOtlGKhtTe1DNAYNB5VzTkPoNoWWutlaBBsoxsrGQQumOnqoCTUhQMjFessKjgjr4--hxS_r5gXNw25xbHkwbhmJ7RVoAwYXdBXf6HXcU1zSeeEsdwCE5Y_UL0f0Q1ziEvy7Z2pu9Aaalkrawp1_g-qnA6noY0zhqG8_yEQR0GbYs4JgzukYfLpxnHm7opzx-JcKc79LM7dFtHL-8RrM2H3W_KrqQLAEchlNfeYHr70H9sfXi2gSQ</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Rahman, Sadia</creator><creator>Haque, Tasmima N.</creator><creator>Sugandhi, Vrashabh V.</creator><creator>Saraswat, Aishwarya L.</creator><creator>Xin, Xiaoban</creator><creator>Cho, Hyunah</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7150-4191</orcidid></search><sort><creationdate>20231001</creationdate><title>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</title><author>Rahman, Sadia ; Haque, Tasmima N. ; Sugandhi, Vrashabh V. ; Saraswat, Aishwarya L. ; Xin, Xiaoban ; Cho, Hyunah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-6a864f3b8e8ae56111f35cc3c9a4fbe39b7b9403f1208d6f5436e5638450d9e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Cell Line, Tumor</topic><topic>Controlled release</topic><topic>Dermatologic agents</topic><topic>Dermatology</topic><topic>Drug Carriers</topic><topic>Drug therapy</topic><topic>Formulae, receipts, prescriptions</topic><topic>Humans</topic><topic>Medical Law</topic><topic>Melanoma</topic><topic>Melanoma - drug therapy</topic><topic>Mice</topic><topic>Micelles</topic><topic>Nanogels</topic><topic>Original Research Article</topic><topic>Paclitaxel</topic><topic>Particle size</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Polyethylene glycol</topic><topic>Polyethylene Glycols</topic><topic>Polylactide-co-glycolide</topic><topic>Skin</topic><topic>Temozolomide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahman, Sadia</creatorcontrib><creatorcontrib>Haque, Tasmima N.</creatorcontrib><creatorcontrib>Sugandhi, Vrashabh V.</creatorcontrib><creatorcontrib>Saraswat, Aishwarya L.</creatorcontrib><creatorcontrib>Xin, Xiaoban</creatorcontrib><creatorcontrib>Cho, Hyunah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahman, Sadia</au><au>Haque, Tasmima N.</au><au>Sugandhi, Vrashabh V.</au><au>Saraswat, Aishwarya L.</au><au>Xin, Xiaoban</au><au>Cho, Hyunah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>40</volume><issue>10</issue><spage>2291</spage><epage>2301</epage><pages>2291-2301</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>In this study, nanogel creams carrying paclitaxel (PTX) and temozolomide (TMZ) were prepared for the topical treatment of melanoma. PTX and TMZ were first loaded in poly-(D,L-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(D,L-lactide-co-glycolide) (PLAG-b-PEG-b-PLGA) thermosensitive nanogels, which made a transition from a free-flowing sol (formation of micellar network) at 25°C with the z-average particle size of c.a. 96 nm to a gel (aggregation of micelles) at 33°C with the z-average particle size of c.a. 427 nm. An anhydrous absorption ointment base, aquaphor, was then added to drug-loaded nanogels to form nanogel creams carrying PTX and TMZ. Nanogel creams permitted controlled release of the payloads and improved the penetration of the payloads through the rodent skin compared to drug(s)-loaded nanogels. PTX and TMZ in a combination were synergistically effective in inhibiting SK-MEL28, A375, and B16-F10 melanoma cancer cells in vitro . Topically applied nanogel creams carrying TMZ/PTX (4 mg/1.5 mg/dose) showed a trend of tumor volume inhibition on B16-F10-bearing xenograft mice in vivo .</abstract><cop>New York</cop><pub>Springer US</pub><pmid>37012533</pmid><doi>10.1007/s11095-023-03506-z</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7150-4191</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0724-8741
ispartof Pharmaceutical research, 2023-10, Vol.40 (10), p.2291-2301
issn 0724-8741
1573-904X
language eng
recordid cdi_proquest_miscellaneous_2795358387
source MEDLINE; SpringerLink Journals
subjects Animals
Biochemistry
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedicine
Cell Line, Tumor
Controlled release
Dermatologic agents
Dermatology
Drug Carriers
Drug therapy
Formulae, receipts, prescriptions
Humans
Medical Law
Melanoma
Melanoma - drug therapy
Mice
Micelles
Nanogels
Original Research Article
Paclitaxel
Particle size
Pharmacology/Toxicology
Pharmacy
Polyethylene glycol
Polyethylene Glycols
Polylactide-co-glycolide
Skin
Temozolomide
title Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A38%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topical%20Cream%20Carrying%20Drug-Loaded%20Nanogels%20for%20Melanoma%20Treatment&rft.jtitle=Pharmaceutical%20research&rft.au=Rahman,%20Sadia&rft.date=2023-10-01&rft.volume=40&rft.issue=10&rft.spage=2291&rft.epage=2301&rft.pages=2291-2301&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-023-03506-z&rft_dat=%3Cgale_proqu%3EA773646598%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2891930291&rft_id=info:pmid/37012533&rft_galeid=A773646598&rfr_iscdi=true